Effect of pretreatment distress on daily fatigue after chemotherapy for breast cancer

Journal of Oncology Practice

Volumn 4, Issue 2, 2008, Pages 59-63

  Higgins, Sara C ^a   Montgomery, Guy H ^a   Raptis, George ^a   Bovbjerg, Dana H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; SEROTONIN 3 AGONIST;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DEPENDENT VARIABLE; DISEASE SEVERITY; EMOTIONAL STRESS; FATIGUE; FEMALE; HUMAN; HYPOTHESIS; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NAUSEA; PREDICTION; VISUAL ANALOG SCALE;

EID: 42549119957     PISSN: 15547477     EISSN: None     Source Type: Journal    
DOI: 10.1200/JOP.0822002     Document Type: Article

References (32)

1. Boehmke MM: Measurement of symptom distress in women with early-stage breast cancer. Cancer Nurs 27:144-152, 2004
2. Hofman M, Ryan JL, Figueroa-Moseley CD, et al: Cancer-related fatigue: The scale of the problem. Oncologist 12:4-10, 2007 (suppl 1)
3. Groopman JE: Fatigue in cancer and HIV/AIDS. Oncology (Huntingt) 12:335-351, 1998
4. Gutstein HB: The biologic basis of fatigue. Cancer 92:1678-1683, 2001
5. Jean-Pierre P, Figueroa-Moseley CD, Kohll S, et al: Assessment of cancer-related fatigue: Implications for clinical diagnosis and treatment. Oncologist 12: 11-21, 2007 (suppl 1)
6. Hartvig P, Aulin J, Hugerth M, et al: Fatigue in cancer patients treated with cytotoxic drugs. J Oncol Pharm Pract 12:155-164, 2006
7. Woo B, Dibble SL, Piper BF, et al: Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum 25:915-920, 1998
8. Bower JE, Ganz PA, Desmond KA, et al: Fatigue in long-term breast carcinoma survivors: A longitudinal investigation. Cancer 106:751-758, 2006
9. Berger AM: Activity/rest patterns and perceived fatigue and sleep quality during the first week of intravenous chemotherapy for early stage breast cancer. Oncol Nurs Forum 22:A54, 1995
10. Molassiotis A, Chan CW: Fatigue patterns in Chinese patients receiving chemotherapy. Eur J Oncol Nurs 5:60-67, 2001
11. Montgomery GH, McClary KA, Bovbjerg DH: Adjuvant therapy for breast cancer and psychological distress. Ann Oncol 7:977-978, 1996
12. Watson M, Meyer L, Thomson A, et al: Psychological factors predicting nausea and vomiting in breast cancer patients on chemotherapy. Eur J Cancer 34:831-837, 1998
13. Higgins SC, Montgomery GH, Bovbjerg DH: Distress before chemotherapy predicts delayed but not acute nausea. Support Care Cancer 15:171-177, 2007
14. Molassiotis A, Yam BM, Yung H, et al: Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients. Support Care Cancer 10:139-145, 2002
15. Kleinman L, Zodet M, Hakim Z, et al: Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual Life Res 9:499-508, 2000
16. Krupp L, LaRocca N, Muir-Nash J, et al: The fatigue severity scale; Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives Neurol 46:1121-1123, 1989
17. Richardson, A: The health diary: An examination of its use as a data collection method. Journal of Advanced Nursing 19: 782-791, 1994
18. Woffe F: Fatigue assessments in rheumatoid arthritis: Comparative performance of visual analog scale and longer fatigue questionnaires in 7760 patients. J Rheumatol 31:1896-1902, 2004
19. Gift AG, Narsavage G: Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care 7:200-204, 1998
20. Breivik EK, Bjomsson GA, Skoviund E: A comparison of pain rating scales by sampling from clinical trial data. Clin J Pain 16:22-28, 2000
21. Hollen PJ, Gralla RJ, Kris MG, et al: A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): Does formal affect patient ratings of symptoms and quality of life? Qual Life Res 14: 837-847, 2005
22. Harboe E, Greve OJ, Beyer M, et al: Fatigue is associated with cerebral white matter hyperintensites in patients with systemic lupus erythematosus. J Neurol Neurosurg Psychiatr 2007; [Epub ahead of print].
23. Schnur JB, Bovbjerg DH, David D, et al: Hypnosis decreases presurgical distress Iin excisional breast biopsy patients. Anesth Analg (in press).
24. de Jong JN, Candel MJ, Schouten HC, et al: Course of mental fatigue and motivation in breast cancer patients receiving adjurant chemotheraphy. Ann Oncol 16:372-382, 2005
25. Irvine D, Vincent L, Graydon JE, et al: The prevalence and correlates of fatigue in patents receiving treatment with cheotherapy and radiotherapy. Cancer Nurs 17:367-378, 1994
26. Theoharides TC, Konstantinidou AD: Corticotropin-releasing hormone and the blood-brain-barrier. Front-Biosci 12:1615-1628, 2007
27. Witek-Janusek L, Gabram S, Mathews HL: Psychologic stress, reduced NK cell activity, and cytokine dysregulation in woman experience diagnostic breast biopsy. Psychoneuroendocrinology 32:22-35, 2007.
28. Schubert C, Hong S, Natarajan L, et al: The association between fatigue and Inflammatory marker levels in cancer patients: A quantitative review. Brain Behav Immun 21:413-427, 2007
29. Cleeland CS, Bennett GJ, Dantzer R, et al: Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97:2919-2925, 2003
30. Bower JE, Ganz PA, Aziz N, et al: Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64:604-611, 2002
31. Wood LJ, Nall LM, Perrin NA, et al: The cancer chemotherapy drug otoposide (VP-16) induces proinflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy-related symptoms. Biol Res Nurs 8:167-169, 2006
32. Plasecki TM, Hufford MR, Solhan M, et al: Assessing clients in their natural environments with electronic diaries: Rationale, benefits, limitations, and barriers. Psychol Assess 19:25-43, 2007